Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association - PubMed (original) (raw)
. 1991 Apr 1;77(7):1516-26.
Affiliations
- PMID: 1849033
Free article
Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association
B Shiramizu et al. Blood. 1991.
Free article
Abstract
We have examined, by Southern blotting, the patterns of chromosomal breakpoint locations in 55 cases of Burkitt's lymphoma (BL) with respect to geography and Epstein-Barr virus (EBV) association. We have confirmed the association between chromosome 8 breakpoint and geography: 74% of endemic (eBL) but only 9% of sporadic BL (sBL) had breakpoints outside the HindIII fragment encompassing the c-myc gene (P2 less than .00001). Conversely, not only did 91% of sBL manifest a rearranged HindIII fragment, but at least 56% of these cases, in contrast to 17% of eBL cases, had a breakpoint within the first exon or intron of c-myc (P2 less than .004). Breakpoints outside the switch mu (S mu) region (ie, the HindIII fragment encompassing S mu) on chromosome 14 were twice as common overall (73%) as those within S mu (27%), but in the 15 tumors with S mu breakpoints, 13 (87%) had a rearranged c-myc gene. Breakpoints outside the HindIII fragment encompassing c-myc on chromosome 8 were predominantly associated with non-S mu breakpoints on chromosome 14 (85%) and this was the combination most frequently associated with eBL (65%; 6% of sBL, P2 less than .00001). In sBL, the most frequent breakpoint combination was a rearranged c-myc gene with a non-S mu breakpoint (63%; 13% of eBL). Twenty-eight percent of sBL and 13% of eBL had breakpoints both within c-myc and within S mu. EBV DNA was present in 19 of 20 tumors with breakpoints outside c-myc, in none of 7 with a breakpoint in the immediate 5' region of c-myc, in 4 of 5 tumors with breakpoints in the first exon, and in 7 of 12 tumors with breakpoints in the first intron. These data suggest that the pathogeneses of eBL and sBL differ with regard to the mechanism of c-myc deregulation, and probably also with regard to the state of differentiation of the target cell for malignant transformation. We have formulated a testable hypothesis regarding the potential role of EBV in pathogenesis: that it is required to contribute to the deregulation of c-myc in the presence of some, but not all, types of c-myc damage arising from the chromosomal translocations.
Similar articles
- Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions.
Gutiérrez MI, Bhatia K, Barriga F, Diez B, Muriel FS, de Andreas ML, Epelman S, Risueño C, Magrath IT. Gutiérrez MI, et al. Blood. 1992 Jun 15;79(12):3261-6. Blood. 1992. PMID: 1317726 - Epstein-Barr virus and Burkitt's lymphoma.
Magrath I, Jain V, Bhatia K. Magrath I, et al. Semin Cancer Biol. 1992 Oct;3(5):285-95. Semin Cancer Biol. 1992. PMID: 1335792 - Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma.
Pelicci PG, Knowles DM 2nd, Magrath I, Dalla-Favera R. Pelicci PG, et al. Proc Natl Acad Sci U S A. 1986 May;83(9):2984-8. doi: 10.1073/pnas.83.9.2984. Proc Natl Acad Sci U S A. 1986. PMID: 3458257 Free PMC article. - Biology of the lymphomas: cytogenetics, molecular biology, and virology.
Ambinder RF, Griffin CA. Ambinder RF, et al. Curr Opin Oncol. 1991 Oct;3(5):806-12. doi: 10.1097/00001622-199110000-00002. Curr Opin Oncol. 1991. PMID: 1661167 Review. - The etiology of Burkitt's lymphoma and the history of the shaken dogmas.
de Thé G. de Thé G. Blood Cells. 1993;19(3):667-73; discussion 674-5. Blood Cells. 1993. PMID: 8018947 Review.
Cited by
- Epstein-Barr virus and Burkitt lymphoma.
Brady G, MacArthur GJ, Farrell PJ. Brady G, et al. J Clin Pathol. 2007 Dec;60(12):1397-402. doi: 10.1136/jcp.2007.047977. J Clin Pathol. 2007. PMID: 18042696 Free PMC article. Review. - Epstein-Barr virus and Burkitt lymphoma.
Rowe M, Fitzsimmons L, Bell AI. Rowe M, et al. Chin J Cancer. 2014 Dec;33(12):609-19. doi: 10.5732/cjc.014.10190. Epub 2014 Nov 21. Chin J Cancer. 2014. PMID: 25418195 Free PMC article. Review. - Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.
Chiorazzi N, Ferrarini M. Chiorazzi N, et al. Blood. 2011 Feb 10;117(6):1781-91. doi: 10.1182/blood-2010-07-155663. Epub 2010 Dec 9. Blood. 2011. PMID: 21148333 Free PMC article. Review. - Burkitt lymphoma: pathogenesis and immune evasion.
God JM, Haque A. God JM, et al. J Oncol. 2010;2010:516047. doi: 10.1155/2010/516047. Epub 2010 Oct 5. J Oncol. 2010. PMID: 20953370 Free PMC article. - The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects.
Nguyen L, Papenhausen P, Shao H. Nguyen L, et al. Genes (Basel). 2017 Apr 5;8(4):116. doi: 10.3390/genes8040116. Genes (Basel). 2017. PMID: 28379189 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials